B. Riley lowered the firm’s price target on Lantheus (LNTH) to $122 from $127 and keeps a Buy rating on the shares. Competitor Telix’s (TLX) ...

In Q4 2024, the Lazard US Equity Concentrated Portfolio underperformed its benchmark. Click here to read the full commentary.

In a regulatory filing, Lantheus ( LNTH) Holdings CFO Robert Marshall Jr. disclosed the sale of 10,000 common shares of the company on March 17 at a price of $100.52 per share. Discover stocks' market ...

Learn more about whether Globus Medical, Inc. or Lantheus Holdings, Inc. is a better investment based on AAII's A+ Investor ...

We recently published a list of 10 Best Healthcare Stocks For Long-Term Investment. In this article, we are going to take a ...

Raymond James Financial Inc. acquired a new position in Lantheus Holdings, Inc. (NASDAQ:LNTH – Free Report) during the fourth ...

Charles Schwab Investment Management Inc. cut its stake in Lantheus Holdings, Inc. (NASDAQ:LNTH – Free Report) by 0.5% in the fourth quarter, according to its most recent 13F filing with the ...

There are lots of interesting companies that make Bedford their home. Below is a quick recap of what’s happening around town ...

As the Q4 earnings season wraps, let’s dig into this quarter’s best and worst performers in the medical devices & supplies - ...

Lantheus Holdings, Inc.'s stock has surged 55% since my last “Buy” rating, driven by strong revenue growth from Pylarify and Definity, and a profitable business model. Strategic acquisitions ...

Detailed price information for Lantheus Holdings (LNTH-Q) from The Globe and Mail including charting and trades.

Lantheus anticipates double-digit growth in 2025 and beyond, fueled by acquisitions and new product launches. The company surpassed $1 billion in cash, providing a strong foundation for ...